Share
Journal Information
Issue
Vol. 44. Issue S1.
Pages S1-S44
(October 2022)
Speaker presentations
Speaker presentations
Pediatric presentations
Oral presentations
Low Incidence of Central Nervous System (CNS) Relapse of Diffuse Large B-Cell Lymphoma despite Limited Use of Intrathecal Prophylaxis
Aamer Aleem, Farjah Algahtani, Omar Aloraini, Ahmed Jamal, Musa Alzahrani, Ghazi Alotaibi, Omar Alayed, Khalid Alsaleh
Hematol Transfus Cell Ther. 2022;44 Supl 1:S13-S14
Open access
AN UPDATED OF PIONEER PROJECT TO COLLECT DATA OF T-CELL NHL PATIENTS AMONG FIVE REGIONS OF BRAZIL. T-CELL BRAZIL PROJECT
Carmino A De SOUZA, Carlos S CHIATTONE, Eliana MIRANDA, Juliana PEREIRA, Karyn Z CECYN, Nelson S CASTRO, Sergio A B BRAZIL, Danielle F C FARIAS, ... Massimo FEDERICO
Hematol Transfus Cell Ther. 2022;44 Supl 1:S14-S15
Open access
UPDATED PROGRESSION-FREE SURVIVAL (PFS) AND DEPTH OF RESPONSE IN IKEMA, A RANDOMIZED PHASE 3 TRIAL OF ISATUXIMAB, CARFILZOMIB AND DEXAMETHASONE (ISA-KD) VS KD IN RELAPSED MULTIPLE MYELOMA (MM)
Ozgur PEKTAS, Philippe MOREAU, Meletios-Athanasios DIMOPOULOS, Joseph MIKHAEL, Kwee YONG, Marcelo CAPRA, Thierry FACON, Roman HAJEK, ... Thomas MARTIN
Hematol Transfus Cell Ther. 2022;44 Supl 1:S15
Open access
Pediatric Acute Myeloid Leukemia (AML): NOTCH1 activation influencing prognosis through Transforming Growth Factor-B (TGF-Beta) / SETBP1; Report of a Pilot Study from Saudi Arabia
GHALEB ELYAMANY, Nawaf ALKHAYAT, Omar AL SHARIF, Yasser ELBORAI, Mohammad AL SHAHRANI, Omar ALSUHAIBANI
Hematol Transfus Cell Ther. 2022;44 Supl 1:S15-S16
Open access
EVALUATION OF COVID-19 FEAR AND QUALITY OF LIFE IN PATIENTS WITH HEMATOPOIETIC STEM CELL TRANSPLANTATION DURING THE COVID-19 PANDEMIC
Serhat Çelik, Zeynep Tuğba Güven, Funda İpekten, Muzaffer Keklik, Ali Ünal, Leylagül Kaynar
Hematol Transfus Cell Ther. 2022;44 Supl 1:S16
Open access
UMBILICAL CORD BLOOD (UCB) AND BONE MARROW (BM) AS A SOURCE OF NATURAL KILLERS (NK) FOR KIR-ALLOREACTIVE ADOPTIVE IMMUNOTHERAPY (KIR-AI)
Kapitolina Melkova, Gennady Frolov, Zhanna Sharoyan
Hematol Transfus Cell Ther. 2022;44 Supl 1:S16-S17
Open access
HUMORAL IMMUNITY RESPONSES AFTER VACCINATION FOR HEPATITIS B VIRUS IN AUTOGRAFTED PATIENTS: A SINGLE CENTER EXPERIENCE
Panayotis Kaloyannidis, Naeema Al Musailemelime, Abdulelah Al Shami, Manal Al Enazi, Norah Al Mulhem, Ahmed Bahrani, Rabab Attas, Solaf Kanfar
Hematol Transfus Cell Ther. 2022;44 Supl 1:S17
Open access
ANTIBODY RESPONSES AND SAFETY OF THE COMMERCIALLY AVAILABLE VACCINES AGAINST SARS-COV-2 VIRUS IN ALLOGRAFTED PATIENTS: REAL WORLD DATA FROM A SINGLE CENTER
Panayotis Kaloyannidis, Belal Blowi, Rana Yahya, Hamdah Al Khaldi, Rabab Attas, Afra Dayel, Solaf Kanfar
Hematol Transfus Cell Ther. 2022;44 Supl 1:S17-S18
Open access
TREATMENT OF A PATIENT DIAGNOSED WITH ERDHEIM CHESTER'S DISEASE IN COOPERATION WITH PLASTIC SURGERY AND HEMATOLOGY
Simge ERDEM, Dilek Özden ÖZLÜK, Erol KOZANOĞLU, Sevgi KALAYOĞLU BEŞIŞIK
Hematol Transfus Cell Ther. 2022;44 Supl 1:S19
Open access
REAL-LIFE STUDY OF BIO-CLINICAL FOLLOW-UP AFTER BNT162b2 mRNA COVID-19 (BNTCV) VACCINATION IN 235 PATIENTS (PTS) INCLUDING 225 WITH HEMATOLOGICAL MALIGNANCIES (HM).
Jean-François Rossi, Emmanuel Bonnet, Marion Velensek, Emma Wisniewski, Sophie Heraud, Rania Boustany, Céleste David, Jérôme Dinet, ... Emmanuel Goffart
Hematol Transfus Cell Ther. 2022;44 Supl 1:S19-S20
Open access
THE EFFECT OF THE COVID-19 PANDEMIC PROCESS ON TREATMENT COMPLIANCE IN HEMOPHILIA PATIENTS
Şifa Şahin, Serap Karaman, Yasin Yılmaz, Mustafa Bilici, Saadet Aslan, Hikmet Gülşah Tanyıldız, Deniz Tuğcu, Zeynep Karakaş, Ayşegül Ünüvar
Hematol Transfus Cell Ther. 2022;44 Supl 1:S21-S22
Open access
Ghosal hematodiaphyseal dysplasia (GHDD) diagnosis and treatment: case report
Gular MAMMADOVA, Samira HASANOVA, Konul BAGHIROVA, Avesta ALLAHVERDIYEVA, Narmin EYVAZOVA, Adam NAJAFLI, Kamala MAMMADOVA, Afag NASIBOVA, Valeh HUSEYNOV
Hematol Transfus Cell Ther. 2022;44 Supl 1:S22-S23
Open access
Comparison of the quality of life of patients with a beta-thalassemia major, regularly receiving parenteral and oral chelators
Samira Hasanova, Azer Kerimov, Khanum Hamidova, Konul Baghirova
Hematol Transfus Cell Ther. 2022;44 Supl 1:S23
Open access
LABORATORY AND CLINICAL FEATURES OF TUMOR LYSIS SYNDROME IN CHILDREN WITH HIGH-GRADE NON-HODGKIN LYMPHOMA AND EVALUATION LONG-TERM RENAL FUNCTIONS IN SURVIVORS
Selcen BOZKURT, Dildar Bahar GENC, Sema VURAL
Hematol Transfus Cell Ther. 2022;44 Supl 1:S23-S24
Open access
IMPACT OF COVID-19 PANDEMIC ON DELAY OF CHILDHOOD CANCER DIAGNOSIS AND THE OUTCOMES IN A PEDIATRIC HEMATOLOGY/ONCOLOGY DEPARTMENT
Selma CAKMAKCI, Neriman SARI, Arzu YAZAL ERDEM, Sonay INCESOY OZDEMIR, Derya OZYORUK, Aslınur OZKAYA PARLAKAY, İnci ERGURHAN ILHAN
Hematol Transfus Cell Ther. 2022;44 Supl 1:S24
Open access
INTRAPLEURAL THERAPY TO DISRUPT IL-6/IL-8 JUXTACTINE SIGNALLING TO BLOCK TUMOR EMT AND TO DRIVE SYSTEMIC ANTI-TUMOR IMMUNITY
Vera Donnenberg, Albert Donnenberg, Ibrahim Sultan, Shannon Puhalla, James Luketich, Christie Hilton, David Bartlett
Hematol Transfus Cell Ther. 2022;44 Supl 1:S24-S25
Open access
Evaluation of Microbiologically Documented Bloodstream Infections in Pediatric Hematology/Oncology Patients: Results of Ten Years
Zehra Aslı İŞERİ KÜSKÜ, Lütfiye ÖKSÜZ, Betigül ÖNGEN, Zeynep KARAKAŞ
Hematol Transfus Cell Ther. 2022;44 Supl 1:S25-S26
Open access
Loading more articles...
Publish in
Hematology, Transfusion and Cell Therapy
